Subversion of host innate immunity by uropathogenic escherichia coli

Pathogens

Volumn 5, Issue 1, 2016, Pages 1-10

  Olson, Patrick D ^a   Hunstad, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystitis; Effectors; Filamentation; Immune evasion; Intracellular bacterial communities; Neutrophils; Urinary tract infection

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOTOXIC NECROTIZING FACTOR 1; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CYSTITIS; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; INNATE IMMUNITY; MICROBIAL COMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; REVIEW; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84992707346     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens5010002     Document Type: Review

References (72)

1. Alto, N.M.; Orth, K. Subversion of cell signaling by pathogens. Cold Spring Harb. Perspect. Biol. 2012, 4, a006114. [CrossRef] [PubMed]
2. Giogha, C.; Lung, T.W.; Pearson, J.S.; Hartland, E.L. Inhibition of death receptor signaling by bacterial gut pathogens. Cytokine Growth Factor Rev. 2014, 25, 235-243. [CrossRef] [PubMed]
3. Krachler, A.M.; Woolery, A.R.; Orth, K. Manipulation of kinase signaling by bacterial pathogens. J. Cell Biol. 2011, 195, 1083-1092. [CrossRef] [PubMed]
4. Silke, J.; Hartland, E.L. Masters, marionettes and modulators: Intersection of pathogen virulence factors and mammalian death receptor signaling. Curr. Opin. Immunol. 2013, 25, 436-440. [CrossRef] [PubMed]
5. Schappert, S.M.; Rechtsteiner, E.A. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. Series 13, Data from the National Health Survey 2011,169,1-38.
6. Litwin, M.S.; Saigal, C.S.; Yano, E.M.; Avila, C.; Geschwind, S.A.; Hanley, J.M.; Joyce, G.F.; Madison, R.; Pace, J.; Polich, S.M.; et al. Urologic diseases in America project: Analytical methods and principal findings. J. Urol. 2005,173, 933-937. [CrossRef] [PubMed]
7. Welch, R.A.; Burland, V.; Plunkett, G., 3rd; Redford, P.; Roesch, P.; Rasko, D.; Buckles, E.L.; Liou, S.R.; Boutin, A.; Hackett, J.; et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 2002, 99,17020-17024. [CrossRef] [PubMed]
8. Hedges, S.; Anderson, P.; Lidin-Janson, G.; de Man, P.; Svanborg, C. Interleukin-6 response to deliberate colonization of the human urinary tract with Gram-negative bacteria. Infect. Immun. 1991, 59, 421-427. [PubMed]
9. Samuelsson, P.; Hang, L.; Wullt, B.; Irjala, H.; Svanborg, C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 2004, 72, 3179-3186. [CrossRef] [PubMed]
10. Song, J.; Duncan, M.J.; Li, G.; Chan, C.; Grady, R.; Stapleton, A.; Abraham, S.N. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 2007, 3, e60. [CrossRef] [PubMed]
11. Andersen-Nissen, E.; Hawn, T.R.; Smith, K.D.; Nachman, A.; Lampano, A.E.; Uematsu, S.; Akira, S.; Aderem, A. Cutting edge: Tlr5~/~ mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 2007,178, 4717-4720. [CrossRef] [PubMed]
12. Smith, N.J.; Varley, C.L.; Eardley, I.; Feather, S.; Trejdosiewicz, L.K.; Southgate, J. Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. J. Urol. 2011,186,1084-1092. [CrossRef] [PubMed]
13. Peck, A.; Mellins, E.D. Precarious balance: Th17 cells in host defense. Infect. Immun. 2010, 78, 32-38. [CrossRef] [PubMed]
14. Sivick, K.E.; Schaller, M.A.; Smith, S.N.; Mobley, H.L. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J. Immunol. 2010,184, 2065-2075. [CrossRef] [PubMed]
15. Chromek, M.; Slamova, Z.; Bergman, P.; Kovacs, L.; Podracka, L.; Ehren, I.; Hokfelt, T.; Gudmundsson, G.H.; Gallo, R.L.; Agerberth, B.; et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 2006,12, 636-641. [CrossRef] [PubMed]
16. Danka, E.S.; Hunstad, D.A. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J. Infect. Dis. 2015,211,1164-1173. [CrossRef] [PubMed]
17. Becknell, B.; Spencer, J.D.; Carpenter, A.R.; Chen, X.; Singh, A.; Ploeger, S.; Kline, J.; Ellsworth, P.; Li, B.; Proksch, E.; et al. Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract. PLoS One 2013, 8, e77714. [CrossRef] [PubMed]
18. Nielsen, K.L.; Dynesen, P.; Larsen, P.; Jakobsen, L.; Andersen, P.S.; Frimodt-Moller, N. Role of urinary cathelicidin LL-37 and human beta-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect. Immun. 2014, 82,1572-1578. [CrossRef] [PubMed]
19. Shahin, R.D.; Engberg, I.; Hagberg, L.; Svanborg Eden, C. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local Gram-negative infection. J. Immunol. 1987, 138, 3475-3480. [PubMed]
20. Haraoka, M.; Hang, L.; Frendeus, B.; Godaly, G.; Burdick, M.; Strieter, R.; Svanborg, C. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 1999,180,1220-1229. [CrossRef] [PubMed]
21. Artifoni, L.; Negrisolo, S.; Montini, G.; Zucchetta, P.; Molinari, P.P.; Cassar, W.; Destro, R.; Anglani, F.; Rigamonti, W.; Zacchello, G.; et al. Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J. Urol. 2007, 177, 1102-1106. [CrossRef] [PubMed]
22. Ingersoll, M.A.; Kline, K.A.; Nielsen, H.V.; Hultgren, S.J. G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell. Microbiol. 2008,10, 2568-2578. [CrossRef] [PubMed]
23. Svensson, M.; Irjala, H.; Svanborg, C.; Godaly, G. Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int. 2008, 74, 81-90. [CrossRef] [PubMed]
24. Svensson, M.; Yadav, M.; Holmqvist, B.; Lutay, N.; Svanborg, C.; Godaly, G. Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCXCR2 heterozygous mice. Kidney Int. 2011, 80, 1064-1072. [CrossRef] [PubMed]
25. Song, J.; Bishop, B.L.; Li, G.; Duncan, M.J.; Abraham, S.N. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 2007,1, 287-298. [CrossRef] [PubMed]
26. Wright, K.J.; Seed, P.C.; Hultgren, S.J. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell. Microbiol. 2007, 9, 2230-2241. [CrossRef] [PubMed]
27. Eto, D.S.; Gordon, H.B.; Dhakal, B.K.; Jones, T.A.; Mulvey, M.A. Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell. Microbiol. 2008, 10, 2553-2567. [CrossRef] [PubMed]
28. Schilling, J.D.; Mulvey, M.A.; Vincent, C.D.; Lorenz, R.G.; Hultgren, S.J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 2001, 166, 1148-1155. [CrossRef] [PubMed]
29. Berry, R.E.; Klumpp, D.J.; Schaeffer, A.J. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect. Immun. 2009, 77, 2762-2772. [CrossRef] [PubMed]
30. Anderson, G.G.; Palermo, J.J.; Schilling, J.D.; Roth, R.; Heuser, J.; Hultgren, S.J. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003, 301,105-107. [CrossRef] [PubMed]
31. Martinez, J.J.; Mulvey, M.A.; Schilling, J.D.; Pinkner, J.S.; Hultgren, S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 2000, 19, 2803-2812. [CrossRef] [PubMed]
32. Mulvey, M.A.; Schilling, J.D.; Hultgren, S.J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 2001, 69, 4572-4579. [CrossRef] [PubMed]
33. Eto, D.S.; Jones, T.A.; Sundsbak, J.L.; Mulvey, M.A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 2007, 3, e100. [CrossRef] [PubMed]
34. Duncan, M.J.; Li, G.; Shin, J.S.; Carson, J.L.; Abraham, S.N. Bacterial penetration of bladder epithelium through lipid rafts. J. Biol. Chem. 2004, 279, 18944-18951. [CrossRef] [PubMed]
35. Bishop, B.L.; Duncan, M.J.; Song, J.; Li, G.; Zaas, D.; Abraham, S.N. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 2007, 13, 625-630. [CrossRef] [PubMed]
36. Eto, D.S.; Sundsbak, J.L.; Mulvey, M.A. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell. Microbiol. 2006, 8, 704-717. [CrossRef] [PubMed]
37. Justice, S.S.; Hung, C.; Theriot, J.A.; Fletcher, D.A.; Anderson, G.G.; Footer, M.J.; Hultgren, S.J. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA 2004, 101, 1333-1338. [CrossRef] [PubMed]
38. Robino, L.; Scavone, P.; Araujo, L.; Algorta, G.; Zunino, P.; Pirez, M.C.; Vignoli, R. Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children. Clin. Infect. Dis. 2014, 59, e158-e164. [CrossRef] [PubMed]
39. Robino, L.; Scavone, P.; Araujo, L.; Algorta, G.; Zunino, P.; Vignoli, R. Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog. Dis. 2013, 68, 78-81. [CrossRef] [PubMed]
40. Rosen, D.A.; Hooton, T.M.; Stamm, W.E.; Humphrey, P.A.; Hultgren, S.J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 2007, 4, e329. [CrossRef] [PubMed]
41. Nicholson, T.F.; Watts, K.M.; Hunstad, D.A. OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect. Immun. 2009, 77,5245-5251. [CrossRef] [PubMed]
42. Justice, S.S.; Hunstad, D.A.; Seed, P.C.; Hultgren, S.J. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl. Acad. Sci. USA 2006, 103, 19884-19889. [CrossRef] [PubMed]
43. Horvath, D.J., Jr.; Li, B.; Casper, T.; Partida-Sanchez, S.; Hunstad, D.A.; Hultgren, S.J.; Justice, S.S. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect. 2011, 13, 426-437. [CrossRef] [PubMed]
44. Justice, S.S.; Hunstad, D.A.; Cegelski, L.; Hultgren, S.J. Morphological plasticity as a bacterial survival strategy. Nat. Rev. Microbiol. 2008, 6, 162-168. [CrossRef] [PubMed]
45. Champion, J.A.; Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA 2006,103, 4930-4934. [CrossRef] [PubMed]
46. Klumpp, D.J.; Weiser, A.C.; Sengupta, S.; Forrestal, S.G.; Batler, R.A.; Schaeffer, A.J. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kB. Infect. Immun. 2001, 69, 6689-6695. [CrossRef] [PubMed]
47. Billips, B.K.; Forrestal, S.G.; Rycyk, M.T.; Johnson, J.R.; Klumpp, D.J.; Schaeffer, A.J. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect. Immun. 2007, 75, 5353-5360. [CrossRef] [PubMed]
48. Hunstad, D.A.; Justice, S.S.; Hung, C.S.; Lauer, S.R.; Hultgren, S.J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 2005, 73, 3999-4006. [CrossRef] [PubMed]
49. Billips, B.K.; Schaeffer, A.J.; Klumpp, D.J. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 2008, 76, 3891-3900. [CrossRef] [PubMed]
50. Vertommen, D.; Ruiz, N.; Leverrier, P.; Silhavy, T.J.; Collet, J.F. Characterization of the role of the Escherichia coli periplasmic chaperone SurA using differential proteomics. Proteomics 2009, 9, 2432-2443. [CrossRef] [PubMed]
51. Hilbert, D.W.; Pascal, K.E.; Libby, E.K.; Mordechai, E.; Adelson, M.E.; Trama, J.P. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide-and Toll-like receptor 4-independent pathway. Microbes Infect. 2008,10,114-121. [CrossRef] [PubMed]
52. Dhakal, B.K.; Mulvey, M.A. The UPEC pore-forming toxin a-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 2012,11, 58-69. [CrossRef] [PubMed]
53. Hilbert, D.W.; Paulish-Miller, T.E.; Tan, C.K.; Carey, A.J.; Ulett, G.C.; Mordechai, E.; Adelson, M.E.; Gygax, S.E.; Trama, J.P. Clinical Escherichia coli isolates utilize a-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect. 2012,14, 628-638. [CrossRef] [PubMed]
54. Cirl, C.; Wieser, A.; Yadav, M.; Duerr, S.; Schubert, S.; Fischer, H.; Stappert, D.; Wantia, N.; Rodriguez, N.; Wagner, H.; et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 2008,14, 399-406. [CrossRef] [PubMed]
55. Yadav, M.; Zhang, J.; Fischer, H.; Huang, W.; Lutay, N.; Cirl, C.; Lum, J.; Miethke, T.; Svanborg, C. Inhibition of tir domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 2010, 6, e1001120. [CrossRef] [PubMed]
56. Lloyd, A.L.; Smith, S.N.; Eaton, K.A.; Mobley, H.L. Uropathogenic Escherichia coli suppresses the host inflammatory response via pathogenicity island genes SisA and SisB. Infect. Immun. 2009, 77, 5322-5333. [CrossRef] [PubMed]
57. Loughman, J.A.; Hunstad, D.A. Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect. 2011,13, 555-565. [CrossRef] [PubMed]
58. Lau, M.E.; Hunstad, D.A. Quantitative assessment of human neutrophil migration across a cultured bladder epithelium. J. Vis. Exp. 2013, e50919. [CrossRef] [PubMed]
59. Lau, M.E.; Loughman, J.A.; Hunstad, D.A. YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration. Infect. Immun. 2012, 80, 4123-4132. [CrossRef] [PubMed]
60. Mellor, A.L.; Munn, D.H. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat. Rev. Immunol. 2004, 4, 762-774. [CrossRef] [PubMed]
61. Loughman, J.A.; Hunstad, D.A. Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J. Infect. Dis. 2012, 205,1830-1839. [CrossRef] [PubMed]
62. Cavalieri, S.J.; Snyder, I.S. Effect of Escherichia coli a-hemolysin on human peripheral leukocyte viability in vitro. Infect. Immun. 1982, 36, 455-461. [PubMed]
63. Russo, T.A.; Davidson, B.A.; Genagon, S.A.; Warholic, N.M.; Macdonald, U.; Pawlicki, P.D.; Beanan, J.M.; Olson, R.; Holm, B.A.; Knight, P.R. E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am. J. Physiol. Lung Cell. Mol. Biol. 2005, 289, L207-L216. [CrossRef] [PubMed]
64. Davis, J.M.; Rasmussen, S.B.; O'Brien, A.D. Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect. Immun. 2005, 73, 5301-5310. [CrossRef] [PubMed]
65. Davis, J.M.; Carvalho, H.M.; Rasmussen, S.B.; O'Brien, A.D. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect. Immun. 2006, 74, 4401-4408. [CrossRef] [PubMed]
66. Lau, M.E.; Danka, E.S.; Tiemann, K.M.; Hunstad, D.A. Bacterial lysis liberates the neutrophil migration suppressor YbcL from the periplasm of uropathogenic Escherichia coli. Infect. Immun. 2014, 82, 4921-4930. [CrossRef] [PubMed]
67. Hagberg, L.; Hull, R.; Hull, S.; McGhee, J.R.; Michalek, S.M.; Svanborg Eden, C. Difference in susceptibility to Gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 1984, 46, 839-844. [PubMed]
68. Godaly, G.; Bergsten, G.; Hang, L.; Fischer, H.; Frendeus, B.; Lundstedt, A.C.; Samuelsson, M.; Samuelsson, P.; Svanborg, C. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukoc. Biol. 2001, 69, 899-906. [PubMed]
69. Hannan, T.J.; Mysorekar, I.U.; Hung, C.S.; Isaacson-Schmid, M.L.; Hultgren, S.J. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 2010, 6, e1001042. [CrossRef] [PubMed]
70. Schwartz, D.J.; Conover, M.S.; Hannan, T.J.; Hultgren, S.J. Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog. 2015,11, e1004599. [CrossRef] [PubMed]
71. Hannan, T.J.; Roberts, P.L.; Riehl, T.E.; van der Post, S.; Binkley, J.M.; Schwartz, D.J.; Miyoshi, H.; Mack, M.; Schwendener, R.A.; Hooton, T.M.; et al. Inhibition of cyclooxygenase-2 prevents chronic and recurrent cystitis. EBiomedicine 2014, 1, 46-57. [CrossRef] [PubMed]
72. Serre, L.; Pereira de Jesus, K.; Zelwer, C.; Bureaud, N.; Schoentgen, F.; Benedetti, H. Crystal structures of YbhB and YbcL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor protein. J. Mol. Biol. 2001, 310, 617-634. [CrossRef] [PubMed]